Table 1 Baseline characteristics of 71 patients who developed ventilator-associated pneumonia
From: Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia
Parameter | Survivors (n = 45) | Nonsurvivors (n = 26) | Total (n = 71) | P value |
|---|---|---|---|---|
Age (years) | 58 ± 14 | 64 ± 16 | 60 ± 15 | 0.12 |
Acute Physiology and Chronic Health Evaluation II score | 18 ± 6 | 22 ± 9 | 19 ± 7 | 0.06 |
Albumin level (mg/dl) | 2.8 ± 0.6 | 2.4 ± 0.5 | 2.7 ± 0.6 | 0.01 |
Gender (%) | 0.09 | |||
Male | 66.7 | 46.2 | 59.2 | |
Female | 33.3 | 53.8 | 40.8 | |
Origin (%) | 0.25 | |||
Medical | 51.1 | 65.4 | 56.3 | |
Surgical | 48.9 | 34.6 | 43.7 | |
Onset (%)a | 0.93 | |||
Early onset | 22.2 | 23.1 | 22.5 | |
Late onset | 77.8 | 76.9 | 77.5 | |
Chronic obstructive pulmonary disease (%) | 17.7 | 26.9 | 19.7 | 0.59 |
Congestive heart failure (%) | 17.8 | 26.9 | 21.1 | 0.37 |
Malignancy (%) | 13.3 | 15.4 | 14.1 | 0.81 |
Histamine type-2 receptor antagonist (%) | 66.7 | 57.7 | 63.4 | 0.45 |
Proton pump inhibitor (%) | 22.2 | 34.6 | 26.8 | 0.26 |
Corticosteroids (%) | 13.3 | 19.2 | 15.5 | 0.51 |
Dialysis (%) | 11.1 | 19.2 | 14.1 | 0.35 |
Smoker (%) | 37.8 | 38.5 | 38.0 | 0.95 |
Septic status (%) | 0.01 | |||
Sepsis | 66.7 | 15.4 | 47.9 | |
Severe sepsis | 28.9 | 30.8 | 29.6 | |
Septic shock | 4.4 | 53,8 | 22.5 |